pharma top-20-pharma-companies-2023-revenue 
Pharmaceutical Technology
MAY 16, 2023
More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61
Pharmaceutical Technology
FEBRUARY 8, 2023
The top 20 companies in the global biopharma industry saw 5.4%* aggregate market capitalization from $3.43 trillion over the past year, according to GlobalData’s Pharma Intelligence Center Companies Database. Johnson & Johnson maintained its top position in 2022, followed by Lilly. trillion to $3.61
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MAY 6, 2024
The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. share of global pharma revenues, according to analysts Statistica 1. for the top five European Union markets and 5.6% In 2022, the continent held a 22.4% respectively compared to an average market growth of 5.8%
Drug Discovery World
MAY 1, 2024
Many of the best-selling drugs in 2023 were monoclonal antibody (mAB) therapies, including Keytruda (pembrolizumab), Humira (adalimumab), and Dupixent (dupilumab) 1. This won’t come as a surprise when you look at industry milestones achieved in 2023 and looking ahead, this shows no signs of slowing down.
XTalks
MAY 2, 2024
In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. According to pharma commercial intelligence and predictive analytics company Evaluate , which releases a list of the most highly anticipated drugs of the year, the top med on the list is an unexpected one that could make big waves.
pharmaphorum
NOVEMBER 14, 2021
After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations. With consumer health splintering off, there is already speculation about a further breakup, with pharma and medical devices also diverging.
Pharma Marketing Network
DECEMBER 17, 2021
The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.
Expert insights. Personalized for you.
130 
Let's personalize your content